Sigvion Capital aims for $100M healthcare-startup fund
Sigvion Capital, a Chicago VC firm specializing in life-science investing, hopes to raise between $50 million and $100 million for its second fund, VentureWire reports (subscription required). The firm anticipates a boom in healthcare startups in the Great Lakes region.
Next Story: InCode BioPharmaceutics raises $2M to target autoimmunity
Previous Story: PTV Sciences raises $190M fund for life-science investments
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.